Merck & Co., Inc. (MRK)
A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.
Recs
SierraBlue
(< 20)
Submitted: 11/17/2009 6:53:38 PM :
Start Price:
$34.27
MRK Score:
+8.04
Mad Money - Cramer Pick
Recs
RubberSoul61
(89.78)
Submitted: 11/9/2009 8:19:16 PM :
Start Price:
$33.51
MRK Score:
+8.69
only good things can happen as result of recent merger
Recs
thackm
(60.01)
Submitted: 11/4/2009 11:54:11 AM :
Start Price:
$32.37
MRK Score:
+9.23
with the merger to SGP. only good things ahead for this stock.
Recs
jcn2u
(75.16)
Submitted: 10/31/2009 7:23:49 PM :
Start Price:
$38.92
MRK Score:
+5.69
They bought SGP on the cheap.
SGP has the pipeline and management that MRK needed.
MRK has the deep pockets to carry through with the drugs in the pipeline, SGP did not.
Now the question is:
Does MRK have the fortitude to do what has to be done with their own management.
We shall see.
IF done correctly MRK has the raw materials to become THE dominate drug company that they were many years ago.
Recs
luremaster
(24.52)
Submitted: 10/31/2009 2:03:02 PM :
Start Price:
$31.12
MRK Score:
+12.07
after buyout will have large cost savings and little overlap of products and a better pipeline of new drugs.
Recs
gtcircus
(68.68)
Submitted: 10/30/2009 11:10:30 AM :
Start Price:
$31.69
MRK Score:
+11.51
health care leader pt 2
Recs
Boredkid
(92.38)
Submitted: 10/27/2009 2:07:38 AM :
Start Price:
$32.59
MRK Score:
+9.63
Low P/E, high dividend yield. Expect patent-losses affect on bottom line to be offset by acquisitions and partnerships; also expect Wall Street to be overly pessimistic about patent expirations.
Recs
snowhippo
(47.13)
Submitted: 10/25/2009 9:17:03 PM :
Start Price:
$32.50
MRK Score:
+11.05
The SGP merger along with other R&D partnerships will yield new profitable drugs. Health care reform in the US will bolster current drugs, even though patent cliffs are looming.
Recs
brianpivar
(96.79)
Submitted: 10/25/2009 6:16:32 PM :
Start Price:
$32.50
MRK Score:
+11.05
They just cvame out with earnings..They beat EPS by .07 beat on revenue, and are up year over year in both EPS and revenue..yet the stock went down this week. It's trading at around 12 p/e look for this stock to trade at around 16 p/e
Recs
germanjuggler
(< 20)
Submitted: 10/20/2009 5:17:28 AM :
Start Price:
$33.91
MRK Score:
+7.99
undervalued.
Recs
siri22
(26.95)
Submitted: 10/19/2009 1:44:49 PM :
Start Price:
$33.60
MRK Score:
+8.97
aging population, good dividend, baby boomers need meds!
Recs
rovobo
(55.93)
Submitted: 10/16/2009 9:42:19 PM :
Start Price:
$33.11
MRK Score:
+9.79
good dividend , health reform should bring this PHARMA up
Recs
Recs
MedullaOblongata
(68.01)
Submitted: 9/24/2009 12:34:35 PM :
Start Price:
$31.79
MRK Score:
+11.35
Merck & Co aquiring SGP! All around the mullberry bush the monkey chased the weasel. All around the mullberry bush "POP" goes the weasel. Ya see whum sayin'?
;-)
Recs
jfsinvest
(30.34)
Submitted: 9/24/2009 10:32:48 AM :
Start Price:
$30.98
MRK Score:
+13.56
Substantial new drug plieline. Acquisitins
Recs
jeffgoz
(< 20)
Submitted: 9/19/2009 11:23:58 AM :
Start Price:
$31.91
MRK Score:
+10.91
Pharms have been hit hard! But there is a new wave of reasearch yeilding exciting new drugs. merck with SGP will finally start making inroads... The big Pharms with cash will now become investment bankers for Startups! Viox is over..... Now we will see exciting new science! Speed to market!!! Look at what Merck did getting Januvia through trials.... the investment in technology and speed to market is greatly improved. On the reseach side Merck and others are seeing fewer compounds making it to phase 1.. However the hit rates are better becasue the screening is better than ever!
Recs
SequoiaStocks
(< 20)
Submitted: 9/18/2009 10:22:05 AM :
Start Price:
$32.26
MRK Score:
+10.35
This account tracks the performance of the investment firm Ruane, Cunniff, and Goldfarb - the investment manager of Sequoia Fund.
Recs
yeraz
(86.10)
Submitted: 9/13/2009 9:18:52 PM :
Start Price:
$27.42
MRK Score:
+7.60
Baby boomers are getting older and sicker, and they will need more drugs. MRK is a major manufacturer of them. Concerns though about their pipeline might limit the growth.
Recs
sandrick
(89.99)
Submitted: 9/13/2009 4:02:15 PM :
Start Price:
$26.10
MRK Score:
+1.03
THIS STOCK MAY GO NEAR $40 AFTER IT CLOSES ON SGP...ALL IT NEEDS A A LITTLE GOOD NEWS AND A SMOOTH TRANSITION.
IF YOU ARE HOLDING...KEEP HOLDING, CONSIDER TAKING PROFITS AS IT NEARS $40 - IT PROBABLY WON'T STATY THERE.
Recs
ebitdat
(76.48)
Submitted: 9/12/2009 1:09:08 PM :
Start Price:
$32.34
MRK Score:
+6.89
The merger should mean nothing but good things
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 373 1 2 3 4 5 6 7 8 9 10 Next »